pharmaceutical investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Silver Dollar Samples Up to 2,753 g/t AgEq in Underground Sampling Campaign at its La Joya Silver Project
Rio Silver Provides Corporate Update as the Company Advances Toward High-Grade Silver Development in Peru